Erenumab for Migraine Treatment - First Real World Data from Germany

被引：0
|
作者：
Naegel, Steffen [1 ,2 ]
Scheffler, Armin [1 ]
Wurthmann, Sebastian F. [1 ]
Holle, Dagny [1 ]
机构：
[1] Univ Hosp Essen, Dept Neurol, Essen, Germany
[2] Univ Hosp Halle, Dept Neurol, Halle, Germany
来源：
CEPHALALGIA | 2019年 / 39卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-LB-078
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [1] First real world evidence data for the new monoclonal antibody Erenumab from specialized migraine centers in Germany
    Schuh, K.
    Koch, M.
    Stude, P.
    Straube, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [2] Real-world data on erenumab interruption in migraine patients in Germany: the SPECTRE study
    Gaul, Charly
    Goebel, Hartmut
    Koch, Mirja
    Weiss, Cordula
    CEPHALALGIA, 2023, 43 (1supp) : 232 - 233
  • [3] Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany
    Hong, Ja Bin
    Lange, Kristin Sophie
    Fitzek, Mira
    Overeem, Lucas Hendrik
    Triller, Paul
    Siebert, Anke
    Reuter, Uwe
    Raffaelli, Bianca
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [4] Final results from a real world evidence study on the treatment of migraine patients with Erenumab In GERMANY (SPECTRE)
    Gaul, C.
    Koch, M.
    Baufeld, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 193 - 193
  • [5] Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany
    Ja Bin Hong
    Kristin Sophie Lange
    Mira Fitzek
    Lucas Hendrik Overeem
    Paul Triller
    Anke Siebert
    Uwe Reuter
    Bianca Raffaelli
    The Journal of Headache and Pain, 24
  • [6] Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany
    Gaul, Charly
    Koch, Mirja
    Weiss, Cordula
    NEUROLOGY, 2023, 100 (17)
  • [7] Erenumab in migraine: the first Italian real-life data
    Barbanti, Piero
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    Vernieri, Fabrizio
    CEPHALALGIA, 2019, 39 : 262 - 263
  • [8] Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
    Gaul, Charly
    Gendolla, Astrid
    Holle, Dagny
    Goebel, Hartmut
    Koch, Mirja
    Baufeld, Caroline
    Weiss, Cordula
    PAIN AND THERAPY, 2024, 13 (06) : 1659 - 1678
  • [9] First insights in real-world effectiveness of erenumab in chronic migraine patients with high burden of disease in Germany from the NTD headache and migraine registry
    Peikert, Andreas
    Koerwer, Monika
    Tozzi, Viola
    Dikow, Heidi
    Rossnagel, Fabian
    Schnabel, Silvio
    Braune, Stefan
    Bergmann, Arnfin
    NEUROLOGY, 2020, 94 (15)
  • [10] First one-year real world evidence data with the monoclonal antibody Erenumab in Germany
    Straube, Andreas
    Stude, Phillip
    Gaul, Charly
    Koch, Mirja
    Schuh, Katrin
    NEUROLOGY, 2020, 94 (15)
12345